New PET scan for finding spread of lobular breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a new type of PET scan using a special tracer (FAPI) to find cancer spread in people with lobular breast cancer when the standard scan was not clear. The goal is to see if this scan can spot more metastatic lesions, which may help guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older (any age above 18 is fine).
- You have been diagnosed with invasive lobular breast cancer (a type of breast cancer).
- You have already had a standard PET scan (called 18F-FDG PET/CT) to check for spread, and the result was negative or unclear for at least one possible spot.
- You are not pregnant or breastfeeding (if you could become pregnant, a pregnancy test will be done).
- You are not currently in another research study that has an exclusion period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special PET scan can better detect invasive lobular breast cancer that has spread. It may help doctors see the cancer more clearly and guide treatment decisions.
This trial tests whether a special PET/CT scan using a tracer called FAPI can better detect if breast cancer has spread to lymph nodes under the arm after neoadjuvant treatment. If successful, it could guide more precise surgery and avoid unnecessary lymph node removal.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This trial tests a new PET scan (called FFNP) to see if it can find which breast cancers stop responding to hormone therapy early. It's for people with advanced hormone-receptor-positive breast cancer who are starting a new endocrine treatment.
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
This study uses a special PET scan (68Ga FAPI) to check if lymph nodes under the arm still have cancer after you finish pre-surgery treatment. It helps doctors see how well the treatment worked before you have surgery.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.